(888) 391-1315

53ab241127ee4a612ed1b0c0_Icon-arrow-top.png

IN THE NEWS

FDA Recalls & Warnings - Gordon Food Service, ConAgra, Tippin's Gourmet Pies

Tuesday, July 26, 2016

The FDA announced a recall by Krispak, Inc. of their Gordon Food Service (GFS) brand of Honey Roasted Peanuts based on the undisclosed presence of pecans in some packages, which may cause aggravation of food allergies in some users.

Agave Dream issued a recall of its Cappuccino Ice Cream brand based on the possible presence of listeria monocytogenes. Listeria is an infection that can cause symptoms ranging from mild to severe, and even death in young children or the elderly.

Read More

DrugNews' Weekly Recap of FDA Recalls & Warnings

Monday, July 11, 2016

This past week, the U.S. Food and Drug Administration took action by issuing recalls or warnings on six products it deemed had unknown dangers to consumers. Three of these were food products and three were prescription drugs.

Here, DrugNews recaps the various warnings and recalls you should know:

Read More

Risperdal Breast Growth Victim Awarded $70 Million

Thursday, July 07, 2016

A young man who developed female-sized breasts after taking the antipsychotic drug Risperdal was awarded $70 million in damages last week by a jury in Philadelphia.

The monster verdict is the largest by far in Risperdal lawsuits to date, and marks the fifth time a jury found drug maker Johnson & Johnson failed to properly warn the public about the risks that the drug can cause gynecomastia, or unnatural breast growth.

Read More

DrugNews' Weekly FDA Recall Run-Down

Wednesday, July 06, 2016

The U.S. Food and Drug Administration issued several recalls and warnings this week that consumers should be aware of. The list ranged from dessert snacks and flour to dietary supplements and diabetes medications.

Here, DrugNews recaps the various warnings and recalls you should know:

Cumberland Farms’ Sea Salt Caramel Delights chocolate treats were recalled after the product was found to contain a peanut allergen not indicated on the packaging.

Read More

Study Shows Savaysa more cost-effective than Xarelto at Stroke Prevention

Tuesday, June 28, 2016

Since 2010, three new blood thinners, Xarelto, Pradaxa and Eliquis, have battled it out for supremacy in the fast-growing novel oral anticoagulant market.

And while Pradaxa was the first to gain FDA approval, Xarelto has reigned as the market leader for years with around twice as many prescriptions as its nearest competitor.

Read More

FDA Strengthens Warnings for Invokana, Farxiga Kidney Damage

Tuesday, June 21, 2016

For the second time in the past year, the US Food and Drug Administration has warned consumers that two popular diabetes medications, Invokana and Farxiga, may be linked to serious side effects.

First, the agency warned of potentially fatal blood acid levels from the drugs in May of 2015, which was followed by required warning label changes in December to address both this and the potential for urinary tract infections.

Read More

Heartburn Meds May Increase Risk of Dementia, Heart and Kidney Problems

Thursday, June 09, 2016

A popular type of over-the-counter heartburn drug taken by millions of people around the world may raise the likelihood of heart attacks, dementia and kidney problems, according to a new study.

The research, published last month, concerns proton pump inhibitors, or PPIs, which are sold under brand names like Nexium. These are not to be confused with other types of heartburn meds called H2 blockers, which are sold under brand names like Zantac.

Read More

New Study Shows Pradaxa Internal Bleeding Risks are Underestimated

Wednesday, June 08, 2016

Doctors from Harvard Medical School and Brigham and Women’s Hospital released a new study last week further questioning the safety of blood thinning drugs like Pradaxa, based on the risks of internal bleeding.

The study comes as the maker of the drug, German pharmaceutical giant Boehringer Ingelheim, prepares to defend thousands more lawsuits from injured patients and their families after paying out an initial $650 million settlement in 2014.

Read More

Antipsychotic Drug Zyprexa Linked to Severe Skin Condition

Wednesday, May 18, 2016

The FDA this month issued a warning to patients taking the antipsychotic drug Zyprexa, advising that they may be at a higher risk for a severe skin condition known as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).

The warning was issued after the agency compiled a higher-than-expected number of reports of patients suffering the potentially deadly condition.

Read More

FDA Warns of Miscarriage Risk from Yeast Infection Drug Diflucan

Thursday, May 12, 2016

The Food and Drug Administration recently added a strong warning to the yeast infection drug Diflucan for women who are pregnant, saying that even small doses have been associated with a higher risk of miscarriage.

Diflucan, taken orally, was approved by the FDA in 1990 and is sold by Pfizer. It is prescribed for a variety of fungal infections in the lungs, bladder, esophagus, mouth and blood, and is also indicated to fight infections in those with cancer or weakened immune systems. But it is used most often for vaginal yeast infections.

Read More

prev 1 2 3 4 5 6 7 8 9 next